scholarly journals IMPACT OF VESSEL CALCIFICATION ON INTIMAL COVERAGE AFTER PACLITAXEL-COATED NITINOL DRUG-ELUTING STENT (ZILVER-PTX) IMPLANTATION IN THE SUPERFICIAL FEMORAL ARTERY

2014 ◽  
Vol 63 (12) ◽  
pp. A1828
Author(s):  
Masashi Fukunaga ◽  
Kenichi Fujii ◽  
Kojiro Miki ◽  
Hiroto Tamaru ◽  
Takahiro Imanaka ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Drug Eluting Stent ◽  
Drug Eluting ◽  
Zilver Ptx

scholarly journals “Low Echoic Area” around stent after bare and drug-coated stenting or stent graft placement for superficial femoral artery disease

2021 ◽  
Vol 9 ◽  
pp. 2050313X2110145
Author(s):  
Yoshimitsu Soga ◽  
Kenji Ando
Keyword(s):  
Stent Graft ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Drug Eluting Stent ◽  
Drug Eluting ◽  
Cook Medical ◽  
Artery Disease ◽  
Zilver Ptx ◽  
Cordis Corporation

Restenosis after stent implantation in femoropopliteal lesions is still big issue. However, restenosis has been reduced by the recent new drug-eluting stent “Eluvia” (Boston Scientific, Marlborough, MA, USA). However, it was reported that “low echoic area (LEA)” finding around stent by ultrasound that they called “aneurysmal degeneration,” but no blood flow was identified outside the stent was confirmed after Eluvia implantation. In this report, we describe the similar findings that were observed after other types of stents (S.M.A.R.T. bare-nitinol stent (Cordis Corporation, Hialeah, FL, USA), Zilver PTX drug-coated stent (Cook Medical, Bloomington, IN, USA), and Viabahn stent graft (W. L. Gore & Associates, Newark, Delaware, USA)) for superficial femoral artery disease. These findings did not change to “aneurysmal change” during the follow-up.

Cost-Effectiveness Analysis of Drug Coated Balloon vs. Drug Eluting Stent in the Superficial Femoral Artery

2017 ◽  
Vol 41 ◽  
pp. 24 ◽  
Author(s):  
Natalie D. Sridharan ◽  
Aureline Boitet ◽  
Kenneth Smith ◽  
Kathy Noorbakhsh ◽  
Efthymios Avgerinos ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Cost Effectiveness Analysis ◽  
Drug Eluting Stent ◽  
Effectiveness Analysis ◽  
Drug Eluting ◽  
Drug Coated Balloon

Abstract 13748: Predictors of Yellow Neointima After Stent Implantation in the Superficial Femoral Artery

Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Takuya Tsujimura ◽  
Takayuki Ishihara ◽  
Osamu Iida ◽  
Shin Okamoto ◽  
Kiyonori Nanto ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Patient Characteristics ◽  
Bare Metal Stent ◽  
Drug Eluting Stent ◽  
Drug Eluting ◽  
Neointimal Coverage

Background: Neoatherosclerosis is known to occur after coronary stenting, but whether it occurs following stenting in the superficial femoral artery (SFA) remains unknown. Methods: This study comprised angioscopic evaluations of 149 stents implanted in the 102 SFA lesions from 92 patients from April 2012 to September 2014. Complete neointimal coverage (defined as struts fully embedded and invisible) was found in 87 stents in the 67 native lesions from the 61 patients. We compared characteristics between the cases with (23 stents, 26%) and without yellow neointima (YN) at the site of complete neointimal coverage, and evaluated the predictors of YN. Results: Median follow-up duration was significantly longer in the YN(+) than YN(-) group (370 [interquartile range: 282-884] days vs. 350 [95-394] days, P<0.001), while patient characteristics, medication use, rate of drug-eluting stent and bare-metal stent use (48% vs. 50%, P=1.0), and lesion and procedural characteristics were similar between them. Low-density lipoprotein cholesterol (LDL-C) level at intervention was higher in the YN(+) than YN(-) group (109±25 mg/dL vs. 97±25 mg/dL, P=0.049). At angioscopic follow-up, LDL and total cholesterol (TC) levels were higher in the YN(+) than YN(-) group (109±27 mg/dL vs. 97±25 mg/dL, P= 0.046; and 188±33 mg/dL vs. 172±34 mg/dL, P=0.048, respectively). Conclusions: YN was associated with the degree of dyslipidemia, suggesting the presence of neoatherosclerosis in the SFA following stenting.

scholarly journals Two-Month Angioscopic Evaluation of Superficial Femoral Artery Treated With Paclitaxel-Coated Nitinol Drug-Eluting Stent

2013 ◽  
Vol 77 (7) ◽  
pp. 1880-1882 ◽  
Author(s):  
Takayuki Ishihara ◽  
Osamu Iida ◽  
Masaki Awata ◽  
Masashi Fujita ◽  
Tetsuya Watanabe ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Drug Eluting Stent ◽  
Drug Eluting
Sign in / Sign up

Export Citation Format

Share Document